MDMA Treatments Found to Eliminate PTSD Symptoms in Phase II Trial
Gavin Davidson, CVMD Analyst, GlobalData, examines how MDMA is used to treat patients with PTSD
Read More...
Trending menu:
-
![]()
Industry Viewpoints: Clinical Trials in Asia – Key Considerations
Mainfong Ang, Amgen, sits down with CTA’s Jisong Seo about the difficulties of clinical operations...
Read More...
-
![]()
How to Enable Greater Budget Forecasting
Ken Olovich, R.Ph., MBA, Sourcing and Financial Director of Chorus, Eli Lilly, explains a model...
Read More...
-
![]()
Poor Communication Can Cost You – REALLY Cost You
Daria Wicks, Director, Clinical Operations, Vericel Corporation, emphasizes the importance of clear communication within an...
Read More...
-
![]()
To Outsource or Not to Outsource? That is the Question
Lisa Henry, Manager of Clinical Research, Cordis, discusses the merits of clinical trial outsourcing models
Read More...
-
![]()
Execution: A Key Success Factor in All Sponsor-CRO Collaborations
Ken Getz, Tufts CSDD, examines why the sponsor-CRO dynamic often falls short of expectations
Read More...
-
![]()
The Stem Cell Emperor’s New Clothes
James L. Sherley, M.D., Ph.D., Founder and Director, Asymmetrex, exposes a problem in the global...
Read More...
-
![]()
Announcing ‘The Return of Outsourcing Week’ on Clinical Trials Arena
Throughout this week, CTA will spotlight the ever-changing outsourcing landscape
Read More...
-
![]()
Patient Recruitment and Retention Considerations for Clinical Trials in Latin America
Wagner Souza, Clinical Research Manager, AstraZeneca Brazil, shares his thoughts about the challenges of patient...
Read More...
-
![]()
How to Manage Specialist Site Payment Providers
Jeff Nelson, VP Program Management, Mateon Therapeutics, explores the rise of specialist payment providers
Read More...
